Clinical Trial

COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics

Study acronym: COVOICE
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated June 15, 2023 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
In some clinical forms of COVID-19, an uncontrolled hyper-inflammatory reaction known as a "cytokine storm" appears abruptly, around day 7, and is associated with rapid respiratory deterioration, requiring hospitalization in an intensive care unit (ICU). At present, although risk factors for this severe form have been described, there are no validated criteria for determining which individual patients will develop this aggravation. The study of respiratory sounds (amplitude, frequency, ...) has made it possible in other respiratory pathologies (e.g., chronic obstructive pulmonary disease) to predict exacerbations several days in advance. Having a predictive respiratory pattern for worsening in COVID-19 would make it possible to anticipate the need for intensive care hospital beds, by means of a tool easily available on a mobile phone.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05892549
Lead Sponsor Direction Centrale du Service de Santé des Armées
Conditions Sars-CoV-2 Infection, COVID-19
Enrollment 1,188 participants
Start Date 2023-06-12
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2023-06-15